Evidence map›Paper›PMID 41777378›Full record

ReviewInternational journal of nanomedicine2026

Cell Membrane-Coated Nanoparticles: Advanced Drug Delivery Systems for Chronic Wound Healing Therapy.

Xuan Zhao, Qinxin Liu, Zhikai Xu, Fan Yang, Zhanfei Li, Xiangjun Bai, Hao Zhu, Yukun Liu, Yuchang Wang

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xuan Zhao *Division of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Qinxin Liu *Division of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Zhikai XuDivision of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Fan YangDivision of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Zhanfei LiDivision of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Xiangjun BaiDivision of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Hao ZhuDepartment of Orthopedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Yukun LiuDepartment of Plastic and Aesthetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Yuchang WangDivision of Trauma Surgery, Emergency Surgery & Surgical Critical, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.ORCID 0000-0003-0947-9823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell membrane-coated nanoparticles (CMNPs) have emerged as a promising platform for targeted drug delivery and therapeutic applications due to their unique properties, such as improved biocompatibility, prolonged circulation time, and ability to mimic natural cell functions. The preparation of CMNPs involves three critical stages: extraction of the cell membrane, preparation of the nanoparticle core, and membrane coating. The cell membrane is isolated through various methods, including hypotonic lysis, freeze-thaw cycles, and centrifugation, with careful attention paid to preserving its integrity and functionality. Nanoparticle cores, which can be organic (eg, PLGA, liposomes) or inorganic (eg, metal-based cores), offer distinct advantages in terms of drug loading capacity, stability, and therapeutic potential. The fusion of the core and the membrane is typically achieved through techniques such as membrane extrusion, sonication, and electroporation. These methods enable the efficient formation of core-shell nanostructures, which can be utilized for a range of biomedical applications, particularly in drug delivery, cancer therapy, and tissue regeneration. This review discusses the key aspects of CMNP preparation, including membrane extraction and purification techniques, core selection, and fusion methods, as well as the current trends and future directions in the development of CMNPs for therapeutic purposes.

Indexed as

Cell MembraneDrug Delivery SystemsNanoparticle Drug Delivery SystemNanoparticlesWound HealingAnimalsHumansNanoparticle Drug Delivery Systemcell membrane-coated nanoparticleschronic wound healingdrug deliverynanoparticleswound healing

Identifiers

PMID41777378
PMCPMC12951873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.